FDA accepts brexpiprazole sNDA for priority review in Alzheimer's agit - The Pharma Letter

Submitted by Anonymous (not verified) on Mon, 01/09/2023 - 10:12

FDA accepts brexpiprazole sNDA for priority review in Alzheimer's agit  The Pharma Letter